New Alzheimer's drugs offer excitement, hope
New therapies for Alzheimer's disease have been greeted with hope and excitement by Alzheimer's patients. But only those at the earliest stages of the disease will be eligible.
Stay updated with breaking news from Daniel Murman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New therapies for Alzheimer's disease have been greeted with hope and excitement by Alzheimer's patients. But only those at the earliest stages of the disease will be eligible.
New therapies for Alzheimer's disease have been greeted with hope and excitement by Alzheimer's patients. But only those at the earliest stages of the disease will be eligible.
A recent study using electronic health records of more than 6 million Americans suggests that adults over 65 with a history of COVID-19 have a significantly higher risk of developing Alzheimer’s disease.
Nebraska officials are predicting a controversial new Alzheimer's drug could drive up state Medicaid costs by more than $16 million annually.